HUTCHMED China is a biopharmaceutical company that discovers, develops and commercialises medicines, chiefly targeted cancer therapies and immunotherapies, for patients in China and other markets. It also runs a consumer health business that makes and sells over-the-counter medicines and health supplements. The company is based in Hong Kong and carries out research, manufacturing and sales through operations in mainland China and elsewhere, serving hospitals, physicians and patients alongside retail consumers of its health products.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 0013, and the price on this page is in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #112 of 2611 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendStrong
83/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average7.2%
From 52-week high-12.2%
MomentumStrong
73/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return25.3%
6-month return-1.8%
12-month, skipping last month-7.2%
Stability (higher is calmer)Strong
73/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)35.6%
Worst drawdown, 1 year (smaller is calmer)-37.8%
LiquidityStrong
92/100
Trades actively.
See the numbers →
Avg daily value traded114.67M HKD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 15.57 – 25.58Daily closes, split-adjusted
Signals
50-day average21.22
200-day average20.84
Golden/death cross (60d)Golden, 6 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)1.00
Technical summary
Daily
Strongly bullish
12 bullish · 4 neutral · 0 bearish
Weekly
Bullish
8 bullish · 1 neutral · 3 bearish
Monthly
Neutral
4 bullish · 1 neutral · 3 bearish
Moving averages (daily)
SMA 10
21.96
Bullish
EMA 10
22.27
Bullish
SMA 20
22.17
Bullish
EMA 20
22.05
Bullish
SMA 50
21.22
Bullish
EMA 50
21.25
Bullish
SMA 100
19.42
Bullish
EMA 100
20.67
Bullish
SMA 200
20.84
Bullish
EMA 200
20.99
Bullish
Oscillators (daily)
RSI (14)
53.87
Neutral
MACD (12, 26)
0.32
Bullish
Momentum (12)
1.09
Bullish
Stochastic %K (14)
52.57
Neutral
Williams %R (14)
-47.43
Neutral
CCI (20)
61.55
Neutral
Pivot points (classic, last session)
S3
20.39
S2
21.23
S1
21.79
Pivot
22.63
R1
23.19
R2
24.03
R3
24.59
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
